According to the report, the genomics services market is anticipated to grow from USD 6.7 Billion in 2025 to USD 16.2 Billion in 2035 at a CAGR of 9.2% during the forecast. The genomics services market is changing rapidly, driven by next-generation sequencing advances and the increasing need for personalized medicine options. Globally, the growth in oncology and rare disease diagnostics is pushing adoption.
Additionally, partnerships between genomic companies and healthcare providers in emerging economies such as India and Brazil are helping extend access to precision testing to not only small segments of key populations through significant collaboration but also precision testing that empowers landscape initiatives in underprivileged regions.
Furthermore, there are training initiatives weaving data science methods (particularly AI-enabled and AI-underpinned styles of analysis) approaches into skill development training and education offerings helping to alleviate shortages of capacity among health care professionals. Not surprisingly, affordability and cost, privacy and data security, and complexity within local regulatory environments. While genomic services shift toward large-scale acceptance globally, numerous segments will transition to integrated platforms powered by artificial intelligence that can be tailored to unique healthcare systems.
The genomics services market is driven by the advancements toward next-generation sequencing (NGS) which are responsible for decreasing the cost and time for genome sequencing. Increasing demand for customized medicine and increasing instances of genetic disease bring about an increasing market potential as both physicians and researchers become more in tune with the need for leveraged genome information for genomic discovery and genomic personalized medicine.
The high costs associated with genomics services, along with the complexity of the genome and data interpretation, are major restricting forces. Additionally, stringent regulatory policies and concerns regarding data privacy and ethical concerns surrounding genetic data are weighty restrictions for continued growth in the application genomics within precision medicine and personalized medicine, specifically in developing and middle-income countries.
Emerging markets provide potential growth opportunities for genomics services as existing healthcare infrastructure improves, and awareness regarding the beneficial and life-saving advantages that genomics can bring about is increased. AI and machine learning will provide improvements to data analytics with genomics, and these technological advancements will contribute to therapies that develop precision medicine, thereby creating more potential to drive growth opportunities for the genomics services market to expand.
The genomics services market is indirectly influenced by global tariff policies, specifically through the increase in costs for laboratory equipment and imported reagents. Tariffs on necessary components, like sequencing machines and consumable items, may lead to increased costs of operating genomics service providers. For example, where there are tariffs on Chinese imports, where many of the components for biotech are sourced, costs may go up by as much as 25%.
Additionally, this stress on expense may affect capital investment for development work, possibly restricting slow movement in genomics services innovation. Providers of genomics services are exploring options to source reagents by near shoring and finding new supply chains to countries with tariffs that are lower than importing components from China.
Key players in the global genomics services market include prominent companies such as Agilent Technologies, Inc., BaseClear B.V., BGI Group, CD Genomics, CosmosID, Eurofins Scientific, F. Hoffmann-La Roche Ltd, Gene by Gene, Ltd., Genewiz (A Brooks Life Sciences Company), Illumina, Inc., Macrogen Inc., MedGenome Labs Ltd., Novogene Co., Ltd., Oxford Nanopore Technologies, PerkinElmer, Inc., QIAGEN N.V., SciGenom Labs Pvt. Ltd., Stratos Genomics (a Roche company), Thermo Fisher Scientific Inc., Veritas Genetics, and other key players, along with several other key players contributing to market growth through innovation, strategic partnerships, and global expansion.
MarketGenics is a global market research and management consulting company empowering decision makers from startups, Fortune 500 companies, non-profit organizations, universities and government institutions. Our main goal is to assist and partner organizations to make lasting strategic improvements and realize growth targets. Our industry research reports are designed to provide granular quantitative information, combined with key industry insights, aimed at assisting sustainable organizational development.
We serve clients on every aspect of strategy, including product development, application modeling, exploring new markets and tapping into niche growth opportunities.
800 N King Street Suite 304 #4208 Wilmington, DE 19801 United States.
+1(302)303-2617
3rd floor, Indeco Equinox, Baner Road, Baner, Pune, Maharashtra 411045 India.
Table of Contents
Note* - This is just tentative list of players. While providing the report, we will cover more number of players based on their revenue and share for each geography
We will customise the research for you, in case the report listed above does not meet your requirements.
Get 10% Free Customisation